Terrence Kearney
No más puestos en curso
Fortuna: 3 M $ al 30/04/2024
Perfil
Terrence C.
Kearney served as an Independent Director at Acceleron Pharma, Inc. from 2014 to 2021.
He also held the position of Independent Director at Innoviva, Inc. from 2014 to 2016.
From 2016 to 2018, he served as an Independent Director at Novartis Gene Therapies, Inc. Mr. Kearney was a Director at Levo Therapeutics, Inc. from 2018 to 2022.
Prior to these roles, he served as an Independent Director at Vertex Pharmaceuticals, Inc. from 2011 to 2024.
Mr. Kearney's former job history also includes serving as Treasurer & Vice President at Abbott Laboratories from 2001 to 2004 and as Chief Operating Officer at Hospira, Inc. from 2006 to 2011.
He completed his undergraduate studies at the University of Illinois and holds an MBA from the University of Denver.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/05/2024 | 6 536 ( 0.00% ) | 3 M $ | 30/04/2024 |
Antiguos cargos conocidos de Terrence Kearney.
| Empresas | Cargo | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Director/Miembro de la Junta | 15/05/2024 |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Director/Miembro de la Junta | 01/06/2022 |
| ACCELERON PHARMA INC. | Director/Miembro de la Junta | 19/11/2021 |
| AVEXIS INC | Director/Miembro de la Junta | 14/05/2018 |
| INNOVIVA, INC. | Director/Miembro de la Junta | 26/04/2016 |
Formación de Terrence Kearney.
| University of Illinois | Undergraduate Degree |
| University of Denver | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| INNOVIVA, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Terrence Kearney
